Opinion
Read expert opinions and analysis on policy, markets, and culture in the cannabis industry.
Opinion · page 12
- CBD Market
Five Key Pointers For US Firms Looking To Enter the European CBD Market
Stuart McKenzie, Founder and CEO of Reakiro, offers some guidance for North American firms looking to Europe’s CBD markets WHILE the CBD boom has been well underway in the US for many years things are just starting to take shape in Europe.
- CBD Market
Novel Food Opens Up ‘A Wealth Of Opportunities For The CBD Industry’ Says The ACI
Dr Paul Duffy, Toxicology Associate, at the ACI, elaborates on its Novel Food applications and the significance of these development for the the CBD industry THIS week marks a significant milestone for the Association for the Cannabinoid Industry (ACI), and our members, as we submit their scientific dossiers to the Food Standards Agency (FSA) for their…
- Opinion
To Co-Pack or Not to Co-Pack?
By: Matt Maurer and James Leech, Cannabis Law Practice Group, Torkin Manes LLP In 2018, on the precipice of cannabis legalization in Canada, Deloitte published a report which surveyed Canadian attitudes and response to the legalization of cannabis.
- Opinion
How to remain agile as a cannabis retailer
By Leandra Reid and Krista Raymer, Vetrina Group If the COVID-19 pandemic has taught us anything, it is that businesses must be agile to survive.
- Opinion
‘The Dutch Bedrocan Medicine Is The Only Viable Option For Treating Many Children’s Epilepsy’
Prof Mike Barnes, one of the UK’s leading cannabis clinicians responds to suggestions that the medicines for UK children with epilepsy can be sourced domestically.
- CBD Market
Cannabis Leader’s New Consultancy Off To A Flyer As It Looks To Fix Some Pressing Industry Issues
HIGH-PROFILE cannabis industry leader Hannah Skingle has launched her own consultancy after a three-year stint as Chief Operations Officer at Dragonfly Biosciences.
- Opinion
Abby And Lucy’s Heartfelt PLEA – ‘We All Need Access To NHS Cannabis Medicines Now’
PLEA was launched in May this year and is already reaching and supporting hundreds of people across the UK fighting to gain access to the medication they so desperately need.
- Opinion
‘Failing’ Government Report Into Medicinal Cannabis Is A ‘Missed Opportunity’
The Advisory Council for the Misuse of Drugs’ recent report on cannabis medicines is a missed opportunity, says Pierre Van Weperen of The Grow Group AS a leading distributor of unlicensed CBMPs in the UK, Grow Pharma welcomes research commissioned by the government into this very exciting and rapidly growing area.
- Opinion
Under the Biden-Harris Presidency The Cannabis Industry Can Deliver A Significant Boost To The Whole US Economy
Ex-pat Brit cannabis entrepreneur Elle Rahman, CEO of Oregon-based OME Health, elaborates on what the recent Election means for the industry in the USA.
- Opinion
Four things we learned from Cannabis + Technology
By Chris Milan, NexTec On October 21st and 22nd, NexTec had the opportunity to present alongside the Business of Cannabis at its annual Cannabis + Technology virtual event.
- Opinion
What We Learned After Two Years of Legalized Cannabis
The new legal status of cannabis in Canada presented retailers with a tremendous opportunity to become first movers in a space that was newly regulated. But setting up a legal cannabis retail business was not without its challenges.
- Opinion
Cannabis Medicine Transforms Student’s Life Leaving Her With A ‘CAN DO’ Attitude
Forzana Nasir – one of the UK’s first medical cannabis patients – tells Sue Kirby how it has changed her life as she prepares to launch a new patient advocacy service: Can Do.
